Brighton Jones LLC Bristol Myers Squibb CO Transaction History

Brighton Jones LLC

  • $2.55 Billion
  • Q3 2024

A detailed history of Brighton Jones LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Brighton Jones LLC holds 14,793 shares of BMY stock, worth $854,443. This represents 0.03% of its overall portfolio holdings.

Number of Shares
14,793
Previous 18,169 18.58%
Holding current value
$854,443
Previous $754,000 1.46%
% of portfolio
0.03%
Previous 0.03%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024
SELL
$39.66 - $51.75 $133,892 - $174,708
-3,376 Reduced 18.58%
14,793 $765,000
Q2 2024

Aug 12, 2024
SELL
$40.25 - $52.99 $38,116 - $50,181
-947 Reduced 4.95%
18,169 $754,000
Q1 2024

May 09, 2024
BUY
$47.98 - $54.4 $79,167 - $89,760
1,650 Added 9.45%
19,116 $1.04 Million
Q4 2023

Feb 05, 2024
SELL
$48.48 - $57.85 $407,619 - $486,402
-8,408 Reduced 32.5%
17,466 $896,000
Q3 2023

Oct 25, 2023
BUY
$57.89 - $64.73 $43,359 - $48,482
749 Added 2.98%
25,874 $1.5 Million
Q2 2023

Jul 31, 2023
BUY
$63.71 - $70.74 $104,356 - $115,872
1,638 Added 6.97%
25,125 $1.61 Million
Q1 2023

May 08, 2023
SELL
$65.71 - $74.53 $7,096 - $8,049
-108 Reduced 0.46%
23,487 $1.63 Million
Q4 2022

Feb 02, 2023
SELL
$68.48 - $81.09 $226,942 - $268,732
-3,314 Reduced 12.32%
23,595 $1.7 Million
Q3 2022

Nov 09, 2022
BUY
$0.13 - $76.84 $100 - $59,320
772 Added 2.95%
26,909 $1.91 Million
Q2 2022

Aug 04, 2022
BUY
$72.62 - $79.98 $25,053 - $27,593
345 Added 1.34%
26,137 $2.01 Million
Q1 2022

May 13, 2022
BUY
$61.48 - $73.72 $125,972 - $151,052
2,049 Added 8.63%
25,792 $1.88 Million
Q4 2021

Feb 03, 2022
BUY
$53.63 - $62.52 $109,458 - $127,603
2,041 Added 9.4%
23,743 $1.48 Million
Q3 2021

Nov 04, 2021
BUY
$59.17 - $69.31 $78,518 - $91,974
1,327 Added 6.51%
21,702 $1.28 Million
Q2 2021

Aug 10, 2021
SELL
$61.91 - $67.42 $30,088 - $32,766
-486 Reduced 2.33%
20,375 $1.36 Million
Q1 2021

May 07, 2021
BUY
$59.34 - $66.74 $189,294 - $212,900
3,190 Added 18.05%
20,861 $1.32 Million
Q4 2020

Feb 10, 2021
SELL
$57.74 - $65.43 $104,971 - $118,951
-1,818 Reduced 9.33%
17,671 $1.1 Million
Q3 2020

Nov 12, 2020
BUY
$57.43 - $63.64 $167,867 - $186,019
2,923 Added 17.64%
19,489 $1.18 Million
Q2 2020

Aug 11, 2020
BUY
$54.82 - $64.09 $183,756 - $214,829
3,352 Added 25.37%
16,566 $974,000
Q1 2020

May 13, 2020
SELL
$46.4 - $67.43 $25,798 - $37,491
-556 Reduced 4.04%
13,214 $737,000
Q4 2019

Feb 07, 2020
BUY
$49.21 - $64.19 $185,472 - $241,932
3,769 Added 37.69%
13,770 $884,000
Q3 2019

Oct 28, 2019
SELL
$42.77 - $50.71 $65,609 - $77,789
-1,534 Reduced 13.3%
10,001 $507,000
Q2 2019

Aug 05, 2019
SELL
$44.62 - $49.34 $16,063 - $17,762
-360 Reduced 3.03%
11,535 $523,000
Q1 2019

Apr 26, 2019
SELL
$45.12 - $53.8 $35,193 - $41,964
-780 Reduced 6.15%
11,895 $567,000
Q4 2018

Feb 08, 2019
BUY
$48.76 - $63.23 $53,977 - $69,995
1,107 Added 9.57%
12,675 $659,000
Q3 2018

Nov 07, 2018
SELL
$55.19 - $62.25 $72,298 - $81,547
-1,310 Reduced 10.17%
11,568 $718,000
Q2 2018

Aug 06, 2018
BUY
$50.53 - $62.98 $72,207 - $89,998
1,429 Added 12.48%
12,878 $713,000
Q1 2018

May 03, 2018
SELL
$59.92 - $68.98 $72,563 - $83,534
-1,211 Reduced 9.57%
11,449 $724,000
Q4 2017

Feb 08, 2018
SELL
$59.94 - $65.35 $147,152 - $160,434
-2,455 Reduced 16.24%
12,660 $776,000
Q3 2017

Nov 08, 2017
SELL
$55.23 - $63.74 $56,279 - $64,951
-1,019 Reduced 6.32%
15,115 $963,000
Q2 2017

Aug 08, 2017
BUY
N/A
16,134
16,134 $899,000

Others Institutions Holding BMY

# of Institutions
2,536
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Brighton Jones LLC Portfolio

Follow Brighton Jones LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brighton Jones LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brighton Jones LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email